Metsera said on Monday that its experimental obesity drug showed significant weight loss and favorable tolerability in mid-stage studies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback